ProNephro

Beyond's analysis on ProNephro

• 2026-09-16 — BioPorto launches first patient enrollment in US validation study for its ProNephro AKI NGAL biomarker test, advancing commercialization of a rapid acute kidney injury diagnostic

Recent news mentioning ProNephro

• 2026-09-16 — First Patient In - BioPorto Initiates Patient Enrollment as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
• 2026-09-16 — Første patient indrulleret - BioPorto har påbegyndt indrullering som en del af ProNephro AKI® U.S. Adult Urine NGAL validerings studiet.

Appears alongside

• BioPorto
• AKI
• NGAL

Browse the full archive →